Results 61 to 70 of about 28,276 (143)

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies

European Journal of Haematology, Volume 116, Issue 3, Page 204-214, March 2026.
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

All‐Cause Mortality in Persons With HIV‐HBV Co‐Infection Treated for HBV in Rwanda: A Population‐Based Cohort Study

Journal of Viral Hepatitis, Volume 33, Issue 3, March 2026.
ABSTRACT Chronic hepatitis B virus (HBV) infection increases the risk of cirrhosis, hepatocellular carcinoma and non‐liver complications. HIV co‐infection accelerates disease progression and increases mortality risk compared to HBV mono‐infection, but its impact among treated individuals is not well documented in Sub‐Saharan Africa.
Jean Damascene Makuza, Michael Law, Joseph Puyat, Alnoor Ramji, Dahn Jeong, Richard L. Morrow, Prince Asumadu Adu, Marie Paul Nisingizwe, Alpamys Issanov, Georgine Cua, Héctor Alexander Velásquez García, Charles Berabose, Albert Tuyishime, Naveed Zafar Janjua   +13 more
wiley   +1 more source

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials

BMC Infectious Diseases, 2011
Background Interferon alpha (IFNα) therapy has been widely used in the treatment of chronic hepatitis B (CHB) for decades. Nucleos(t)ide analogues are also increasingly used to treat CHB recently.
Zhang Yu-guo, Ren Wei-guang, Kong Ling-bo, Wang Mao-rong, Li Wen-cong, Nan Yue-min   +5 more
doaj   +1 more source

Detection of the YMDD Motif Mutations Rate in Chronic Hepatitis B Patients Treated with Lamivudine

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2011
Background and Objectives: Lamivudine is the first nucleoside analogue licensed for the treatment of chronic hepatitis B patients which is effective in suppressing virus replication and results in reduced disease activity.
R Rafiei Tabatabaei, R Ehsani, A Pouryasin, A Soudbakhsh, H Sharafi   +4 more
doaj  

Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B

Brazilian Journal of Infectious Diseases
BACKGROUND AND AIM: Chronic hepatitis B is a highly prevalent disease worldwide, leading to serious consequences if not properly treated. Six treatment options for chronic hepatitis B are currently provided by the Brazilian public health system ...
Astrid Wiens, Rafael Venson, Cassyano Januário Correr, Roberto Pontarolo   +3 more
doaj   +1 more source

Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection

Asian Journal of Transfusion Science, 2011
Background: Lamivudine is an analog nucleoside used for the treatment of chronic hepatitis B virus (CHV) infection. Studies showed that prolonged therapy could induce lamivudine resistance hepatitis B virus (HBV) variants (YMDD motif). In this study, the
Ghandehari Freshte, Pourazar Abasali, Zadeh Mehrnaz, Tajedin Nahid   +3 more
doaj  

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection

HIV/AIDS: Research and Palliative Care, 2019
Francis J Zamora,1,2 Ellen Dowers,2 Faiza Yasin,3 Onyema Ogbuagu3 1Department of Pharmacy Services, Broward Health Medical Center, Fort Lauderdale, FL, USA; 2Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT, USA; 3Section of ...
Zamora FJ, Dowers E, Yasin F, Ogbuagu O
doaj  

Incidence and determinants of excessive weight gain in people living with HIV initiating tenofovir, lamivudine, and dolutegravir-based therapy: a multicenter retrospective study in northwest Ethiopia

Frontiers in Pharmacology
BackgroundThe incidence and nature of excessive weight gain associated with antiretroviral treatment using tenofovir, lamivudine, and dolutegravir based regimens among patients living with human immunodeficiency virus has not been properly examined in ...
Gashaw Sisay Chanie, Wagaye Atalay, Tirsit Ketsela Zeleke, Zemenu Wube Bayleyegn, Yonas Sisay Aragie, Gizachew Kassahun Bizuneh, Mihret Melese, Rahel Belete Abebe   +7 more
doaj   +1 more source

Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa

Brazilian Journal of Infectious Diseases
The coinfection of HIV and hepatitis B virus (HBV) and their vertical transmission constitute a public health problem in sub-Saharan countries of Africa.
Denise Ilboudo, Jacques Simpore, Djeneba Ouermi, Cyrille Bisseye, Tani Sagna, Silvia Odolini, Fabio Buelli, Virginio Pietra, Salvatore Pignatelli, Charlemagne Gnoula, Jean-Baptiste Nikiema, Salvatore Musumeci   +11 more
doaj   +1 more source

Immunovirological treatment out- comes after 2 years of antiretroviral therapy in children living with the human immune deficiency virus in Lagos Nigeria

Nigerian Journal of Paediatrics
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O, Akindele AJ, Akanmu AS, Adeyemi OO   +3 more
doaj